What DRG International does

DRG International, Inc. is a privately held, New Jersey-incorporated specialty diagnostics company founded in 1970 by Dr. Cyril E. Geacintov. It manufactures and distributes in-vitro diagnostic (IVD) reagents, ELISA kits, and automated immunoassay/clinical chemistry analyzers to clinical laboratories, research institutions, and microbiology labs. The company offers more than 1,000 products spanning tumor markers, thyroid function, fertility, infectious diseases, endocrinology, and veterinary diagnostics, with the DRG:HYBRiD-XL compact benchtop analyzer serving as the central instrument platform and the Hepcidin 25 (Bioactive) HS assay positioned as a gold-standard correlate to Mass Spectrometry. DRG also distributes the CHROMagar chromogenic culture media line under license across clinical bacteriology, food/water testing, and industrial microbiology applications.

The business operates a hybrid go-to-market combining a US-direct e-commerce store, wholly-owned subsidiaries in Germany, Poland, Russia, and the Czech Republic, and an authorized distributor network spanning 110+ countries (including named partners in Brazil, Vietnam, Kyrgyzstan, Argentina, and Peru). Revenue mechanics are anchored in unit-priced catalog sales of ELISA kits (per-kit pricing disclosed ranges from approximately $146 for AFP to $876 for Chromogranin A) and hardware sales of analyzers and consumable cartridges. Customer evidence skews toward academic and clinical research users (e.g., MRC Gambia, Pennington Biomedical Research Center, Aghia Sophia Children's Hospital, Sanglah General Hospital, Prodia Laboratory), with HYBRiD-XL installations at distributor sites such as URF in Kyrgyzstan.

DRG maintains ISO 13485:2016 and MDSAP certifications, CE marking on the HYBRiD-XL, FDA compliance on key SKUs, Health Canada registration, and has earned the DEQAS Certificate of Proficiency for its 25-OH Vitamin D ELISA. The company operates event-driven demand generation through annual participation in AACC, Arab Health, ENDO, Medlab, Euromed, and Hospitalar conferences. Following the founder's passing in 2017, control remains under private/family ownership with no disclosed venture capital or private equity backing; specific post-transition operating cadence data is not publicly disclosed.

Name

DRG International

Legal name

DRG International, Inc.

Website

https://drg-international.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

11–50 employees

Short description

DRG International is a privately held US-based manufacturer and distributor of in-vitro diagnostic products, including ELISA kits, the DRG:HYBRiD-XL automated immunoassay analyzer, and distributed chromogenic culture media, serving clinical laboratories and research institutions across 110+ countries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• In vitro diagnostics
• ELISA kits
• Immunoassay analyzers
• Clinical chemistry reagents
• Tumor marker assays

Headquarters

HQ city

Springfield

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic ELISA Kits: Sale of enzyme-linked immunosorbent assay (ELISA) kits for various diagnostic applications including tumor markers, thyroid function, fertility/pregnancy, infectious diseases, immunology/hematology, and more. Products sold in multiple formats including manual ELISA and automated formats for HYBRiD-XL.
2. Laboratory Equipment/Analyzers: Sale of the DRG:HYBRiD-XL automated analyzer and related equipment to clinical laboratories. The analyzer is a compact benchtop system capable of running both immunoassays and clinical chemistry tests.
3. CHROMagar Products: Distribution of CHROMagar chromogenic culture media products for clinical bacteriology, industrial microbiology, food and beverage quality control, water testing, and environmental monitoring.
4. Ameritox Labs: Therapeutic and toxicology screening products through Ameritox Labs brand.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

DRG International manufactures and distributes a 1,000+ product portfolio of in vitro diagnostic solutions centered on ELISA kits (covering tumor markers, thyroid function, fertility/pregnancy, infectious disease, immunology/hematology, endocrinology, and bone metabolism) and the proprietary DRG:HYBRiD-XL fully automated random access analyzer for immunoassays and clinical chemistry. The company also distributes CHROMagar chromogenic culture media products for clinical bacteriology, industrial microbiology, and food/water testing applications across 110+ countries.

Product overview

DRG International is a multinational medical equipment and diagnostics manufacturer and distributor offering more than 1,000 products through its multinational network across 110+ countries. The product portfolio is organized around several core platforms: the DRG:HYBRiD-XL fully automated random access analyzer for immunoassays and clinical chemistry serving as the central instrument platform; specialized ELISA kits including the Hepcidin 25 (Bioactive) HS as a gold-standard assay, Salivary ELISA Kits for non-invasive hormone testing, and comprehensive RUO ELISA product lines covering allergy, anemia, autoimmune, tumor markers, thyroid function, and infectious diseases; distributed chromogenic culture media through CHROMagar partnership; and ancillary analyzers like DS2, DSX, and Immu F6 from BioCheck. The company operates without a unified software platform but focuses on hardware-based diagnostic solutions.

Differentiator

Problem solved

Functional benefit

Brands

• DRG:HYBRiD-XL: Fully automated random access analyzer for immunoassays and clinical chemistry
• DRG Diagnostics
• CHROMagar

Products and services

• DRG:HYBRiD-XL Automated Analyzer Fully automated, random access, compact benchtop analyzer that combines immunoassays and clinical chemistry testing on a single platform. Handles up to 40 tests per run (same test or mixed), runs up to 120 tests/day with first results in as little as 10 minutes. Features barcode/QR scanning, 8.5 inch color touchscreen, clot detection, and liquid level detection. CE marked and FDA compliant. Designed for medium and small clinical laboratories.
• Hepcidin 25 (Bioactive) HS ELISA Kit High-sensitivity ELISA kit for quantitative measurement of bioactive Hepcidin 25 in serum and plasma. 96-well microplate format, total assay time of 2 hours with reagents ready to use. Validated against Mass Spectrometry in the first-ever Hepcidin Proficiency Test. Available for both manual ELISA workflows and automated use on the DRG:HYBRiD-XL analyzer. Used by research institutions for iron metabolism and anemia studies.
• DRG Salivary ELISA Kits Easy-to-use, non-invasive salivary assay ELISA kits for measuring hormones and biomarkers in saliva samples. Product line includes Cortisol, DHEA, DHEA-S, Estradiol, 17a OH Progesterone, Estriol, Progesterone, Estrone, IgA, and Testosterone tests. Designed for stress, fertility, endocrinology, and pediatric research applications.
• CHROMagar Chromogenic Culture Media Chromogenic microbiology culture media for clinical bacteriology, industrial microbiology, food and beverage quality control, water testing, and environmental monitoring. DRG distributes all 28 CHROMagar products for detection and differentiation of pathogens including E. coli, Salmonella, Staph aureus, Candida albicans, E. coli O157, Group B Strep, Listeria, Vibrio, and Pseudomonas. Soluble colorless chromogens produce distinct colony colors for rapid identification without specialized lighting.
• RUO ELISA Kits (Research Use Only) Research Use Only enzyme immunoassay ELISA kits covering a broad diagnostic menu including tumor markers (CA 125, CA 15-3, CA 19-9, CA 72-4, CYFRA 21-1, AFP, CEA, Chromogranin A, free and total PSA, NSE), thyroid function, fertility and pregnancy, infectious disease, allergy, anemia, autoimmune markers, bone and mineral metabolism (25-OH Vitamin D, Cystatin C), cardiovascular/hypertension, endocrinology, growth factors, and immunology/hematology. Each kit priced between approximately $146 and $876.
• Ameritox Labs Therapeutic and Toxicology Screening Products Therapeutic drug monitoring and toxicology screening products offered through DRG's Ameritox Labs brand, including assays for clinical and research toxicology applications.
• DS2 Automated Analyzer (Distributed) Featured automated analyzer product offered through DRG International in partnership with BioCheck, Inc. Refer to BioCheck for full technical specifications.
• DSX Automated Analyzer (Distributed) Featured automated analyzer product offered through DRG International in partnership with BioCheck, Inc. Refer to BioCheck for full technical specifications.
• Immu F6 Immunochemistry Analyzer (Distributed) Featured immunochemistry analyzer offered through DRG International in partnership with BioCheck, Inc. Used for clinical immunology and hormone testing. Refer to BioCheck for full technical specifications.

Quantifiable outcome

• First results ready in as little as 10 minutes with DRG:HYBRiD-XL analyzer
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• CHROMagarcoreChannel Partner/ Reseller/ Distributor · 5 September 2016DRG International is an authorized distributor for CHROMagar chromogenic culture media products. DRG distributes all 28 CHROMagar products for clinical bacteriology, industrial microbiology, food and beverage quality control, water testing, and environmental monitoring applications. CHROMagar technology uses proprietary chromogenic differentiation methods invented by founder Alain Rambach.
• URF (Kyrgyzstan)coreChannel Partner/ Reseller/ DistributorURF is the exclusive distributor for DRG products in Kyrgyzstan. They have installed 3 DRG:HYBRiD-XL analyzers and registered 28 assays. Currently registering 6 additional assays including Hepcidin 25 (bioactive) and Calprotectin.
• Biomedix (Brazil)coreChannel Partner/ Reseller/ DistributorBiomedix is the authorized distributor for DRG products in Brazil. DRG participated with Biomedix in Hospitalar 2016 exhibition in Sao Paulo with great success.
• Phu Gia (Vietnam)coreChannel Partner/ Reseller/ DistributorPhu Gia is a longtime distributor of DRG products in Vietnam. They displayed products at the HCM Medical University Biochemistry Congress in 2016.
• Bioanalytical SRL (Argentina)minorChannel Partner/ Reseller/ DistributorBioanalytical SRL is a distributor for DRG products in Argentina, visited after Hospitalar 2016 exhibition.
• Vikmar S.A.C. (Peru)minorChannel Partner/ Reseller/ DistributorVikmar S.A.C. is a distributor for DRG products in Peru, visited after Hospitalar 2016 exhibition.
• Radboud University Medical Center (Netherlands)coreStrategic or Co-development PartnerOrganized the first-ever Hepcidin Proficiency Test in collaboration with SKML (Dutch Foundation for Quality Assessment in Medical Laboratories). The study validated DRG:HYBRiD-XL Hepcidin 25 (bioactive) testing against mass spectrometry reference methods with 19 participating laboratories worldwide.
• BIT (Product Design Partner)coreTechnology or IntegrationBIT is the product design and manufacturing partner for the DRG:HYBRiD-XL automated analyzer. BIT stated: 'It is the Evolution of the Revolution!!' regarding the product design.

Scale indicators4 records

Recent moves11 records

Expansion highlights5 records

Direct peers

• Calbiotech: Calbiotech is a specialty IVD manufacturer focused on ELISA kits for tumor markers, endocrinology, infectious disease, and autoimmune panels — closely overlapping with DRG's RUO ELISA catalog and small/mid-lab customer base.
• Monobind Inc. Monobind manufactures immunoassay kits (ELISA, CLIA, RIA) for endocrinology and reproductive health — overlapping with DRG's thyroid, fertility, and salivary hormone ELISA menus.
• BioCheck, Inc. BioCheck manufactures ELISA kits and clinical chemistry analyzers (DS2, DSX, Immu F6) that DRG actively distributes. Same specialty IVD reagent and small-platform analyzer niche with overlapping immunoassay menus.
• Eagle Biosciences: Eagle Biosciences distributes and manufactures specialty ELISA and assay kits across endocrinology, cancer, cardiac, and inflammation — directly comparable to DRG's RUO ELISA portfolio and research/lab customer segments.
• ALPCO Diagnostics: ALPCO specializes in immunoassays and ELISA kits for hormones, metabolism, and specialty biomarkers, serving research and clinical labs globally — same specialty IVD reagent niche as DRG with similar distribution-driven go-to-market.

Broad incumbents

• DiaSorin S.p.A. DiaSorin is a global specialty IVD player with LIAISON analyzers and broad immunoassay menus (including vitamin D and infectious disease) — a much larger incumbent that competes with DRG in vitamin D and specialty immunoassays.
• bioMérieux: bioMérieux is a global microbiology and IVD leader; its microbiology product line directly overlaps with the CHROMagar chromogenic culture media business DRG distributes.
• Roche Diagnostics: Roche operates the cobas analyzer family with broad immunoassay and clinical chemistry menus, including tumor markers and infectious disease — represents the high-volume incumbent against which DRG's compact HYBRiD-XL competes.
• Abbott Diagnostics: Abbott's Architect and Alinity immunoassay/clinical chemistry platforms serve the same small/mid clinical lab segments as HYBRiD-XL but with substantially higher throughput and broader menus.

Emerging players

• Tosoh Bioscience: Tosoh offers AIA and ST AIA-PACK immunoassay analyzers and reagents — a mid-sized specialty incumbent competing with HYBRiD-XL in compact immunoassay/clinical chemistry benchtop segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/drg_worldwide
• Facebookfacebook.com/DRGInternational
• LinkedInlinkedin.com/company/drg-international-inc-
• Instagraminstagram.com/drg_international

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DRG International